Open Clinical Trials for Veterans With Suicidal Ideation

Providing access to clinical trials for veteran patients can be a challenge, but a significant number of trials are now recruiting patients from those patient populations. The VA Office of Research and Development alone sponsors or cosponsors > 1000 trials. The clinical trials listed below are all open as of September 27, 2019 and are focused exclusively on suicide among US veterans. For additional information and full inclusion/exclusion criteria, please consult


Using Telehealth to Improve Outcomes in Veterans at Risk for Suicide

The investigators will randomize 120 veterans in this 3-site trial over 16 months. Eligible veterans will include those to be discharged for a hospitalization for suicidal ideation. Baseline data collection and randomization will occur at discharge. The 3-month intervention will have study assessments at 2, 4, 8, and 12 weeks postdischarge. The study’s primary outcome measure is suicidal ideation (measured with the Beck Scale for Suicidal Ideation (BSS) and secondarily with the Columbia Scale for Suicidality (C-SSRS).

ID: NCT03724370
Sponsor: VA Pittsburgh Healthcare System
Contact: Gretchen Haas, PhD,; Crystal Spotts, MEd,
Locations: James J. Peters Medical Center, Bronx, New York; VA NY Harbor Healthcare System, Manhattan Campus; VA Pittsburgh Healthcare System, Pennsylvania

Click here to continue reading.

Next Article:

Firearm-related deaths show recent increase

Related Articles